PNPLA3 and metabolic dysfunction-associated steatotic liver disease: As PNPLA3 I148M is a well‐known risk genotype for NAFLD, while those with PNPLA3 I148I are protected from NAFLD, we sought to determine whether these two genotypes mediate different inflammatory responses.